Semler Research Center Appoints New President, Executive Director
Dr Bopanna will primarily be based in Bangalore, India, and he will also have an office at the Corporate HQ in North Hollywood, CA, USA. Prior to joining
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Althea Technologies said that applications of this protein crystal technology range from therapeutics to protein purification and catalysis. The controlled release injectable technology involves protein crystallisation and complexation
Following the recommendation for regulatory approval under the European decentralised procedure, Toctino has received national regulatory approval in Italy and was accepted for reimbursement. Basilea Pharmaceutica claimed that